发明名称 MU-CONOPEPTIDES
摘要 The present invention is to .mu.-conopeptides, derivatives or pharmaceutical ly acceptable salts thereof. The present invention is further directed to the u se of this peptide, derivatives thereof and pharmaceutically acceptable salts thereof for the treatment of disorders associated with voltage-gated sodium channels. Thus, the .mu.-conopeptides or derivatives are useful as neuromuscular blocking agents, local anesthetic agents, analgesic agents and neuroprotective agents. The .mu.-conopeptides are also useful for treating neuromuscular disorders. The invention is further directed to nucleic acid sequences encoding the .mu.-conopeptides and encoding propeptides, as well a s the propeptides.
申请公布号 CA2416544(A1) 申请公布日期 2002.01.31
申请号 CA20012416544 申请日期 2001.07.23
申请人 UNIVERSITY OF UTAH RESEARCH FOUNDATION;COGNETIX, INC. 发明人 JACOBSEN, RICHARD B.;CARTIER, G. EDWARD;JONES, ROBERT M.;SHON, KI-JOON;OLIVERA, BALDOMERO M.;MCINTOSH, J. MICHAEL;GARRETT, JAMES E.;CRUZ, LOURDES J.;WATKINS, MAREN;SHEN, GREGORY S.;WAGSTAFF, JOHN D.
分类号 G01N33/50;A61K35/56;A61K38/00;A61P3/08;A61P3/10;A61P3/12;A61P9/10;A61P15/00;A61P17/00;A61P17/02;A61P21/00;A61P21/02;A61P23/00;A61P23/02;A61P25/00;A61P25/02;A61P25/04;A61P25/08;A61P25/18;A61P25/28;A61P27/02;A61P29/00;A61P35/00;A61P39/00;A61P43/00;C07K14/435;C12N15/09;C12N15/12;G01N33/15;G01N33/58;G01N33/68;(IPC1-7):C12N15/12;A61K38/17;C07K14/47;G01N33/53;G01N33/534 主分类号 G01N33/50
代理机构 代理人
主权项
地址